1. Home
  2. RGP vs AARD Comparison

RGP vs AARD Comparison

Compare RGP & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.46

Market Cap

149.5M

ML Signal

HOLD

Logo Aardvark Therapeutics Inc.

AARD

Aardvark Therapeutics Inc.

HOLD

Current Price

$5.95

Market Cap

165.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
AARD
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.5M
165.8M
IPO Year
2000
2025

Fundamental Metrics

Financial Performance
Metric
RGP
AARD
Price
$4.46
$5.95
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$7.00
$15.29
AVG Volume (30 Days)
267.4K
116.2K
Earning Date
04-08-2026
05-14-2026
Dividend Yield
6.85%
N/A
EPS Growth
79.14
43.11
EPS
N/A
N/A
Revenue
$452,006,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$3.35
52 Week High
$5.55
$17.94

Technical Indicators

Market Signals
Indicator
RGP
AARD
Relative Strength Index (RSI) 58.02 45.48
Support Level $4.17 $5.12
Resistance Level $4.54 $6.43
Average True Range (ATR) 0.13 0.82
MACD 0.01 -0.14
Stochastic Oscillator 89.02 29.41

Price Performance

Historical Comparison
RGP
AARD

About RGP Resources Connection Inc.

Resources Connection Inc is a professional services firm. Its segments include On-Demand Talent provides businesses with a go-to source for bringing in experts when its needed, serving the office of the CFO; Consulting drives transformation across people, processes and technology across domain areas including finance, technology and digital, risk and compliance and operational performance; Europe & Asia Pacific offers both on-demand and consulting services to clients throughout Europe and Asia Pacific; Outsourced Services; and Sitrick. It derives the majority of revenue from On-Demand Talent segment. Geographically, it operates in United States and internationally.

About AARD Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Share on Social Networks: